Letter to the EditorSuccessful Treatment with Gefitinib in Advanced Non–Small Cell Lung Cancer after Acquired Resistance to Osimertinib
Under an Elsevier user license
open archive
Cited by (0)
Disclosure: The authors declare no conflict of interests.
© 2017 International Association for the Study of Lung Cancer. Published by Elsevier Inc.